相关实验视频
Updated: Mar 31, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
CMT2D神经病变与糖基-tRNA合成酶的新型结合活性有关
Weiwei He1, Ge Bai2, Huihao Zhou1
1Departments of Chemical Physiology and Cell and Molecular Biology, The Scripps Research Institute, La Jolla, California 92037, USA.
糖基转移RNA合成酶 (GlyRS) 的突变通过启用新的结合活性导致夏科-玛丽-图斯病2D. 这种异常的GlyRS与神经素1结合,阻断生存信号,导致运动神经元退化.
科学领域:
- 神经科学
- 遗传学
- 分子生物学
背景情况:
- 查科-玛丽-牙 (CMT) 疾病是常见的遗传性神经病,缺乏有效的治疗方法.
- 2D型CMT (CMT2D) 源于GARS中的主导突变,该突变编码蛋白转移RNA合成酶 (GlyRS),该基因对蛋白质合成至关重要.
- 尽管GlyRS的表达无处不在,但CMT2D中运动神经元的选择性脆弱性尚未得到充分理解.
研究的目的:
- 阐明CMT2D相关的GlyRS突变导致选择性运动神经元退化的分子机制.
- 确定由突变的GlyRS破坏的特定分子相互作用和途径.
主要方法:
- 研究了突变GlyRS (GlyRS ((CMT2D)) 的新形结合活性.
- 分析了GlyRS (CMT2D) 和神经皮林1 (Nrp1) 受体之间的相互作用.
- 评估了GlyRS (CMT2D) 对血管内皮生长因子 (VEGF) 信号的影响.
- 使用了对Nrp1和VEGF表达进行基因操纵的小鼠模型.
主要成果:
- CMT2D突变诱导GlyRS的形状变化,从而产生新型结合活性.
- 异常地与Nrp1结合,竞争性地抑制VEGF结合.
- 在小鼠中,Nrp1的遗传减少加剧了CMT2D症状.
- 在CMT2D模型中,增强VEGF表达改善了运动功能.
结论:
- 在CMT2D中,选择性病理与GlyRS ((CMT2D) 与Nrp1的新型结合有关,对抗VEGF信号传递.
- VEGF-Nrp1信号轴代表了CMT2D的潜在治疗目标.
更多相关视频
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
08:03Protein-tRNA Agarose Gel Retardation Assays for the Analysis of the N6-threonylcarbamoyladenosine TcdA Function
Published on: June 21, 2017
相关概念视频
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Ligand Binding and Linkage
tRNA Activation
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...